previous compound ID: 1723 next compound
InChIKey: PMGQWSIVQFOFOQ-YKVZVUFRSA-N
SMILES: C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C.C(=C/C(=O)O)\C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "R Robert" "GW Carlile" "J Goepp" "JW Hanrahan" "SD Macknight" "J Liao" "D Rotin" "E Matthes" "DY Thomas"

chemical graph of compound 1723





CID is 5281069
synonyms found at PubChem are:
CLEMASTINE FUMARATE, 14976-57-9, Agasten, Tavist, Mecloprodine, Aloginan, Xolamin, Alphamin, Anhistan, Clemanil, Fuluminol, Inbestan, Kinotomin, Lacretin, Lecasol, Maikohis, Marsthine, Masletine, Piloral, Reconin, Trabest, Mallermin-F, Telgin-G, Tavist-1, Tavegil, Tavegyl, Clemastine hydrogen fumarate, Clemastine (fumarate), Meclastine hydrogen fumarate, UNII-19259EGQ3D, HSDB 6507, Contac 12 Hour Allergy, EINECS 239-055-2, CHEBI:3739, 19259EGQ3D, C21H26ClNO.C4H4O4, (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine fumarate (1:1), (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl pyrrolidine fumarate, (R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate, DSSTox_CID_27765, DSSTox_RID_82542, DSSTox_GSID_47785, (R-(R*,R*))-2-(2-(1-(p-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium hydrogen fumarate, Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-, fumarate (1:1), Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-, (E)-2-butenedioate (1:1), Topcare dayhist allergy, NCGC00016710-01, CAS-14976-57-9, (R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate, Meclastine fumarate, (E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine, Prestwick_680, Clemastine fumarate [USAN:BAN:JAN], AC1NQXZB, Clemastinefumarate,(S), Clemastine fumarate [USAN:USP:BAN:JAN], clemastine; fumaric acid, SCHEMBL33403, SCHEMBL41468, SPECTRUM1500191, Tavist;Xolamin;Agasten;Aloginan, CHEMBL1200795, DTXSID6047785, HMS500O07, HY-B0298A, MolPort-003-666-146, PMGQWSIVQFOFOQ-YKVZVUFRSA-N, HMS1568N14, HMS1920O13, HMS2091E20, HMS2095N14, HMS3267L12, HMS3712N14, Pharmakon1600-01500191, BCP27945, Tox21_110574, CCG-40028, NSC756685, s1847, AKOS015896237, Tox21_110574_1, AC-1338, CS-2331, NSC-756685, NCGC00016710-05, NCGC00180903-01, NCGC00180903-02, AS-12093, BC206422, Clemastine fumarate salt, >=98% (HPLC), AB2000329, LS-137507, ST24046356, K-4763, 976C579, SR-05000001590, I06-2109, SR-05000001590-1, Clemastine fumarate, European Pharmacopoeia (EP) Reference Standard, Clemastine fumarate, United States Pharmacopeia (USP) Reference Standard, (2R)-2-[2-[(1R)-1-(4-Chlorophenylethoxy]ethyl]-1-methyl-2-pyrrolidine fumarate, Clemastine for system suitability, European Pharmacopoeia (EP) Reference Standard, (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine (2E)-but-2-enedioate, (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate, (E)-but-2-enedioic acid; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine, Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-,fumarate (1:1), Hydroxyclemastine, D06QQS, AC1O52GA, (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidin-1-ium; (E)-4-hydroxy-4-oxobut-2-enoate